Cardiovascular Health Promotion in Children: Challenges and Opportunities for 2020 and Beyond: A Scientific Statement from the American Heart Association

Circulation

Volumn 134, Issue 12, 2016, Pages e236-e255

  Steinberger, Julia ^a   Daniels, Stephen R ^a   Hagberg, Nancy ^a   Isasi, Carmen R ^a   Kelly, Aaron S ^a   Lloyd Jones, Donald ^a   Pate, Russell R ^a   Pratt, Charlotte ^a   Shay, Christina M ^a   Towbin, Jeffrey A ^a   Urbina, Elaine ^a   Van Horn, Linda V ^a   Zachariah, Justin P ^a  

^a NONE

Author keywords

AHA Scientific Statements; blood pressure; body mass index; cholesterol; diet; glucose; pediatrics; physical activity; smoking

Indexed keywords

CHOLESTEROL; GLUCOSE; LIPID;

ADOLESCENT HEALTH; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CHILD HEALTH; CHOLESTEROL BLOOD LEVEL; DIET; GLUCOSE BLOOD LEVEL; HEALTH PROMOTION; HUMAN; LIPID BLOOD LEVEL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SMOKING; ADOLESCENT; ADULT; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS; MALE; MEDICAL SOCIETY; ORGANIZATION AND MANAGEMENT; PHYSIOLOGY; RISK FACTOR; UNITED STATES;

ADOLESCENT; ADULT; AMERICAN HEART ASSOCIATION; CARDIOVASCULAR DISEASES; FEMALE; HEALTH BEHAVIOR; HEALTH PROMOTION; HEALTH STATUS; HUMANS; MALE; RISK FACTORS; SMOKING; UNITED STATES;

EID: 84988841999     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000441     Document Type: Article

References (123)

1. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD; American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586-613. doi: 10.1161/CIRCULATIONAHA.109.192703.
2. Cali AM, Caprio S. Obesity in children and adolescents. J Clin Endocrinol Metab. 2008;93(suppl 1):S31-S36. doi: 10.1210/jc.2008-1363.
3. Chiarelli F, Marcovecchio ML. Insulin resistance and obesity in childhood. Eur J Endocrinol. 2008;159(suppl 1):S67-S74. doi: 10.1530/EJE-08-0245.
4. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics. 1999;103(pt 1):1175-1182.
5. Freedman DS, Mei Z, Srinivasan SR, Berenson GS, Dietz WH. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr. 2007;150:12-17.e2. doi: 10.1016/j.jpeds.2006.08.042.
6. Goodman E, Dolan LM, Morrison JA, Daniels SR. Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation. 2005;111:1970-1977. doi: 10.1161/01.CIR.0000161957.34198.2B.
7. Nathan BM, Moran A. Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes Obes. 2008;15:21-29. doi: 10.1097/MED. 0b013e3282f43d19.
8. Sinaiko AR, Steinberger J, Moran A, Prineas RJ, Vessby B, Basu S, Tracy R, Jacobs DR Jr. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation. 2005;111:1985-1991. doi: 10.1161/01.CIR.0000161837.23846.57.
9. Wärnberg J, Marcos A. Low-grade inflammation and the metabolic syndrome in children and adolescents. Curr Opin Lipidol. 2008;19:11-15. doi: 10.1097/MOL.0b013e3282f4096b.
10. Jolliffe D. Extent of overweight among US children and adolescents from 1971 to 2000. Int J Obes Relat Metab Disord. 2004;28:4-9. doi: 10.1038/sj.ijo.0802421.
11. Freedman DS, Khan LK, Serdula MK, Ogden CL, Dietz WH. Racial and ethnic differences in secular trends for childhood BMI, weight, and height. Obesity (Silver Spring). 2006;14:301-308. doi: 10.1038/oby.2006.39.
12. Strauss RS, Pollack HA. Epidemic increase in childhood overweight, 1986-1998. JAMA. 2001;286:2845-2848.
13. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010;303:242-249. doi: 10.1001/jama. 2009.2012.
14. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012;307:483-490. doi: 10.1001/jama.2012.40.
15. Sinaiko AR, Jacobs DR Jr, Steinberger J, Moran A, Luepker R, Rocchini AP, Prineas RJ. Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr. 2001;139:700-707. doi: 10.1067/mpd.2001.118535.
16. Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation. 1995;91:2400-2406. doi: 10.1161/01. CIR.91.9.2400.
17. Urbina EM, Gidding SS, Bao W, Elkasabany A, Berenson GS. Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: the Bogalusa Heart Study. Am Heart J. 1999;138(pt 1):122-127.
18. Li X, Li S, Ulusoy E, Chen W, Srinivasan SR, Berenson GS. Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study. Circulation. 2004;110:3488-3492. doi: 10.1161/01.CIR.0000149713.48317.27.
19. Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, Srinivasan SR, Daniels SR, Davis PH, Chen W, Sun C, Cheung M, Viikari JS, Dwyer T, Raitakari OT. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011;365:1876-1885. doi: 10.1056/NEJMoa1010112.
20. Chen W, Srinivasan SR, Li S, Xu J, Berenson GS. Metabolic syndrome variables at low levels in childhood are beneficially associated with adulthood cardiovascular risk: the Bogalusa Heart Study. Diabetes Care. 2005;28:126-131.
21. Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Mäki-Torkko N, Järvisalo MJ, Uhari M, Jokinen E, Rönnemaa T, Akerblom HK, Viikari JS. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290:2277-2283. doi: 10.1001/jama.290.17.2277.
22. Raitakari OT, Juonala M, Viikari JS. Obesity in childhood and vascular changes in adulthood: insights into the Cardiovascular Risk in Young Finns Study. Int J Obes (Lond). 2005;29(suppl 2):S101-S104.
23. Freedman DS, Dietz WH, Tang R, Mensah GA, Bond MG, Urbina EM, Srinivasan S, Berenson GS. The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study. Int J Obes Relat Metab Disord. 2004;28:159-166. doi: 10.1038/sj.ijo.0802515.
24. Oikonen M, Laitinen TT, Magnussen CG, Steinberger J, Sinaiko AR, Dwyer T, Venn A, Smith KJ, Hutri-Kähönen N, Pahkala K, Mikkilä V, Prineas R, Viikari JS, Morrison JA, Woo JG, Chen W, Nicklas T, Srinivasan SR, Berenson G, Juonala M, Raitakari OT. Ideal cardiovascular health in young adult populations from the United States, Finland, and Australia and its association with cIMT: the International Childhood Cardiovascular Cohort Consortium. J Am Heart Assoc. 2013;2:e000244. doi: 10.1161/JAHA.113.000244.
25. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311:806-814. doi: 10.1001/jama.2014.732.
26. Skinner AC, Skelton JA. Prevalence and trends in obesity and severe obesity among children in the United States, 1999-2012. JAMA Pediatr. 2014;168:561-566. doi: 10.1001/jamapediatrics. 2014.21.
27. Kelly AS, Barlow SE, Rao G, Inge TH, Hayman LL, Steinberger J, Urbina EM, Ewing LJ, Daniels SR; on behalf of the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young, Council on Nutrition, Physical Activity and Metabolism, and Council on Clinical Cardiology. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association. Circulation. 2013;128:1689-1712. doi: 10.1161/CIR. 0b013e3182a5cfb3.
28. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med. 1998;338:1650-1656. doi: 10.1056/NEJM199806043382302.
29. McGill HC Jr, McMahan CA, Gidding SS. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation. 2008;117:1216-1227. doi: 10.1161/CIRCULATIONAHA.107.717033.
30. Engeland A, Bjørge T, Søgaard AJ, Tverdal A. Body mass index in adolescence in relation to total mortality: 32-year follow-up of 227,000 Norwegian boys and girls. Am J Epidemiol. 2003;157: 517-523.
31. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992;327:1350-1355. doi: 10.1056/NEJM199211053271904.
32. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(suppl 4th report):555-576.
33. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report. Pediatrics. 2011;128:S213-S256. doi: 10.1542/peds.2009-2107C.
34. Barlow SE; Expert Committee. Expert Committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(suppl 4):S164-S192. doi: 10.1542/peds. 2007-2329C.
35. American Academy of Pediatrics, National Cholesterol Education Program: report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89(pt 2): 525-584.
36. Type 2 diabetes in children and adolescents: American Diabetes Association. Diabetes Care. 2000;23:381-389. http://dx.doi. org/10.2337/diacare.23.3.381.
37. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11. 2002:1-190.
38. Berenson GS, Srinivasan SR, Cresanta JL, Foster TA, Webber LS. Dynamic changes of serum lipoproteins in children during adolescence and sexual maturation. Am J Epidemiol. 1981;113:157-170.
39. deGroot I, Morrison JA, Kelly KA, Rauh JL, Mellies MJ, Edwards BK, Glueck CJ. Lipids in schoolchildren 6 to 17 years of age: upper normal limits. Pediatrics. 1977;60:437-443.
40. Moran A, Jacobs DR Jr, Steinberger J, Hong CP, Prineas R, Luepker R, Sinaiko AR. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48:2039-2044.
41. van Stiphout WA, Hofman A, de Bruijn AM, Valkenburg HA. Distributions and determinants of total and high-density lipoprotein cholesterol in Dutch children and young adults. Prev Med. 1985;14:169-180.
42. Huang TT, Nansel TR, Belsheim AR, Morrison JA. Sensitivity, specificity, and predictive values of pediatric metabolic syndrome components in relation to adult metabolic syndrome: the Princeton LRC Follow-Up Study. J Pediatr. 2008;152:185-190. doi: 10.1016/j.jpeds.2007.08.007.
43. Friedman LA, Morrison JA, Daniels SR, McCarthy WF, Sprecher DL. Sensitivity and specificity of pediatric lipid determinations for adult lipid status: findings from the Princeton Lipid Research Clinics Prevalence Program Follow-up Study. Pediatrics. 2006;118:165-172. doi: 10.1542/peds.2005-2968.
44. Magnussen CG, Thomson R, Cleland VJ, Ukoumunne OC, Dwyer T, Venn A. Factors affecting the stability of blood lipid and lipoprotein levels from youth to adulthood: evidence from the Childhood Determinants of Adult Health Study. Arch Pediatr Adolesc Med. 2011;165:68-76. doi: 10.1001/archpediatrics. 2010.246.
45. Magnussen CG, Raitakari OT, Thomson R, Juonala M, Patel DA, Viikari JS, Marniemi J, Srinivasan SR, Berenson GS, Dwyer T, Venn A. Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study. Circulation. 2008;117:32-42. doi: 10.1161/CIRCULATIONAHA. 107.718981.
46. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, Mc-Crindle B, Mietus-Snyder ML. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009;119:628-647. doi: 10.1161/CIRCULATIONAHA. 108.191394.
47. Greenlund KJ, Johnson C, Wattigney W, Bao W, Webber LS, Berenson GS. Trends in cigarette smoking among children in a southern community, 1976-1994: the Bogalusa Heart Study. Ann Epidemiol. 1996;6:476-482.
48. Centers for Disease Control and Prevention. Smoking and tobacco use: data and statistics. 2014. http://www.cdc.gov/tobacco/data-statistics/. Accessed August 15, 2015.
49. Kabir Z, Connolly GN, Alpert HR. Secondhand smoke exposure and neurobehavioral disorders among children in the United States. Pediatrics. 2011;128:263-270. doi: 10.1542/peds.2011-0023.
50. Bunnell RE, Agaku IT, Arrazola RA, Apelberg BJ, Caraballo RS, Corey CG, Coleman BN, Dube SR, King BA. Intentions to smoke cigarettes among never-smoking US middle and high school electronic cigarette users: National Youth Tobacco Survey, 2011-2013. Nicotine Tob Res. 2015;17:228-235. doi: 10.1093/ntr/ntu166.
51. Wills TA, Knight R, Williams RJ, Pagano I, Sargent JD. Risk factors for exclusive e-cigarette use and dual e-cigarette use and tobacco use in adolescents. Pediatrics. 2015;135:e43-e51. doi: 10.1542/peds.2014-0760.
52. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL. CDC Growth Charts: United States. Adv Data. 2000:1-27.
53. Heo M, Wylie-Rosett J, Pietrobelli A, Kabat GC, Rohan TE, Faith MS. US pediatric population-level associations of DXA-measured percentage of body fat with four BMI metrics with cutoffs. Int J Obes (Lond). 2014;38:60-68. doi: 10.1038/ijo.2013.134.
54. Wells JC. Toward body composition reference data for infants, children, and adolescents. Adv Nutr. 2014;5:320S-329S. doi: 10.3945/an.113.005371.
55. Wells JC, Williams JE, Chomtho S, Darch T, Grijalva-Eternod C, Kennedy K, Haroun D, Wilson C, Cole TJ, Fewtrell MS. Pediatric reference data for lean tissue properties: density and hydration from age 5 to 20 y. Am J Clin Nutr. 2010;91:610-618. doi: 10.3945/ajcn.2009.28428.
56. Pintauro SJ, Nagy TR, Duthie CM, Goran MI. Cross-calibration of fat and lean measurements by dual-energy X-ray absorptiometry to pig carcass analysis in the pediatric body weight range. Am J Clin Nutr. 1996;63:293-298.
57. Wells JC, Williams JE, Chomtho S, Darch T, Grijalva-Eternod C, Kennedy K, Haroun D, Wilson C, Cole TJ, Fewtrell MS. Body-composition reference data for simple and reference techniques and a 4-component model: a new UK reference child. Am J Clin Nutr. 2012;96:1316-1326. doi: 10.3945/ajcn.112.036970.
58. Addo OY, Himes JH. Reference curves for triceps and subscapular skinfold thicknesses in US children and adolescents. Am J Clin Nutr. 2010;91:635-642. doi: 10.3945/ajcn.2009.28385.
59. Chumlea WC, Guo SS, Kuczmarski RJ, Flegal KM, Johnson CL, Heymsfield SB, Lukaski HC, Friedl K, Hubbard VS. Body composition estimates from NHANES III bioelectrical impedance data. Int J Obes Relat Metab Disord. 2002;26:1596-1609. doi: 10.1038/sj.ijo.0802167.
60. Shay CM, Ning H, Daniels SR, Rooks CR, Gidding SS, Lloyd-Jones DM. Status of cardiovascular health in US adolescents: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2005-2010. Circulation. 2013;127:1369-1376. doi: 10.1161/CIRCULATIONAHA.113.001559.
61. Del Pino DL, Friedman R. Adaptation and validation of an FFQ for 6-10-year-old children. Public Health Nutr. 2011;14:826-834. doi: 10.1017/S1368980010003538.
62. Lillegaard IT, Løken EB, Andersen LF. Relative validation of a precoded food diary among children, under-reporting varies with reporting day and time of the day. Eur J Clin Nutr. 2007;61:61-68. doi: 10.1038/sj.ejcn.1602487.
63. Paxton A, Baxter SD, Fleming P, Ammerman A. Validation of the school lunch recall questionnaire to capture school lunch intake of third-to fifth-grade students. J Am Diet Assoc. 2011;111:419-424. doi: 10.1016/j.jada.2010.11.017.
64. Wilson A, Magarey A, Mastersson N. Reliability of questionnaires to assess the healthy eating and activity environment of a child's home and school. J Obes. 2013;2013:720368. doi: 10.1155/2013/720368.
65. Hernández-Avila M, Romieu I, Parra S, Hernández-Avila J, Madrigal H, Willett W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex. 1998;40:133-140.
66. Lyons GK, Woodruff SI, Candelaria JI, Rupp JW, Elder JP. Development of a protocol to assess dietary intake among Hispanics who have low literacy skills in English. J Am Diet Assoc. 1996;96:1276-1279. doi: 10.1016/S0002-8223(96)00333-1.
67. Mayer-Davis EJ, Vitolins MZ, Carmichael SL, Hemphill S, Tsaroucha G, Rushing J, Levin S. Validity and reproducibility of a food frequency interview in a Multi-Cultural Epidemiology Study. Ann Epidemiol. 1999;9:314-324.
68. US Department of Health and Human Services. Dietary Guidelines for Americans, 2015. Washington, DC: US Government Printing Office; 2015. http://health.gov/dietaryguidelines/2015/. Accessed November 16, 2015.
69. Caspersen CJ. Physical activity epidemiology: concepts, methods, and applications to exercise science. Exerc Sport Sci Rev. 1989;17:423-473.
70. US Department of Health and Human Services. 2008 Physical Activity Guidelines for Americans. 2008. http://health.gov/paguidelines/. Accessed November 16, 2015.
71. Troiano RP, Berrigan D, Dodd KW, Mâsse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc. 2008;40:181-188. doi: 10.1249/mss.0b013e31815a51b3.
72. Pate RR, O'Neill JR, Mitchell J. Measurement of physical activity in preschool children. Med Sci Sports Exerc. 2010;42:508-512. doi: 10.1249/MSS.0b013e3181cea116.
73. Trost SG, McIver KL, Pate RR. Conducting accelerometer-based activity assessments in field-based research. Med Sci Sports Exerc. 2005;37(suppl):S531-S543.
74. Eaton DK, Kann L, Kinchen S, Shanklin S, Flint KH, Hawkins J, Harris WA, Lowry R, McManus T, Chyen D, Whittle L, Lim C, Wechsler H; Centers for Disease Control and Prevention (CDC). Youth risk behavior surveillance: United States, 2011. MMWR Surveill Summ. 2012;61:1-162.
75. US Department of Health and Human Services, Centers for Disease Control and Prevention. Results from the School Health Policies and Practices Study 2012. http://www.cdc.gov/healthyyouth/shpps/2012/pdf/shpps-results-2012.pdf. Accessed November 16, 2015.
76. Cresanta JL, Srinivasan SR, Webber LS, Berenson GS. Serum lipid and lipoprotein cholesterol grids for cardiovascular risk screening of children. Am J Dis Child. 1984;138:379-387.
77. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood: the Bogalusa Heart Study. Am J Epidemiol. 1991;133: 884-899.
78. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494-2497. doi: 10.1161/01.CIR.0000145117.40114.C7.
79. Messiah SE, Carrillo-Iregui A, Garibay-Nieto G, Lopez-Mitnik G, Cossio S, Arheart KL. Inter-and intra-ethnic group comparison of metabolic syndrome components among morbidly obese adolescents. J Clin Hypertens (Greenwich). 2010;12:645-652. doi: 10.1111/j.1751-7176.2010.00337.x.
80. Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens. 1995;8:657-665. doi: 10.1016/0895-7061(95)00116-7.
81. Flynn JT, Daniels SR, Hayman LL, Maahs DM, McCrindle BW, Mitsnefes M, Zachariah JP, Urbina EM; on behalf of the American Heart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension. 2014;63:1116-1135. doi: 10.1161/HYP.0000000000000007.
82. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F; German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions [published correction appears in J Hypertens. 2003;21:2205-2206]. J Hypertens. 2002;20:1995-2007.
83. Sharma S, Lustig RH, Fleming SE. Identifying metabolic syndrome in African American children using fasting HOMA-IR in place of glucose. Prev Chronic Dis. 2011;8:A64.
84. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37:S14-S80.
85. Cassidy JP, Luzio SD, Marino MT, Baughman RA. Quantification of human serum insulin concentrations in clinical pharmacokinetic or bioequivalence studies: what defines the "best method"? Clin Chem Lab Med. 2012;50:663-666. doi: 10.1515/cclm-2011-0860.
86. Cook PR, Glenn C, Armston A. Effect of hemolysis on insulin determination by the Beckman Coulter Unicell DXI 800 immunoassay analyzer. Clin Biochem. 2010;43:621-622. doi: 10.1016/j.clinbiochem.2010.01.002.
87. Vogeser M, Parhofer KG. Comparison of automated insulin assays. Clin Lab. 2007;53:557-560.
88. Buse JB, Kaufman FR, Linder B, Hirst K, El Ghormli L, Willi S; HEALTHY Study Group. Diabetes screening with hemoglobin A(1c) versus fasting plasma glucose in a multiethnic middleschool cohort. Diabetes Care. 2013;36:429-435. doi: 10.2337/dc12-0295.
89. Svec F, Nastasi K, Hilton C, Bao W, Srinivasan SR, Berenson GS. Black-white contrasts in insulin levels during pubertal development: the Bogalusa Heart Study. Diabetes. 1992;41: 313-317.
90. Burke GL, Webber LS, Srinivasan SR, Radhakrishnamurthy B, Freedman DS, Berenson GS. Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa Heart Study. Metabolism. 1986;35: 441-446.
91. Jolliffe CJ, Janssen I. Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria. J Am Coll Cardiol. 2007;49:891-898. doi: 10.1016/j. jacc.2006.08.065.
92. Whitt-Glover MC, Taylor WC, Floyd MF, Yore MM, Yancey AK, Matthews CE. Disparities in physical activity and sedentary behaviors among US children and adolescents: prevalence, correlates, and intervention implications. J Public Health Policy. 2009;30(suppl 1):S309-S334. doi: 10.1057/jphp.2008.46.
93. US Department of Agriculture, US Department of Health and Human Services. Dietary Guidelines for Americans, 2010. Washington, DC: US Government Printing Office; December 2010.
94. Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, Bell R, Badaru A, Talton JW, Crume T, Liese AD, Merchant AT, Lawrence JM, Reynolds K, Dolan L, Liu LL, Hamman RF; SEARCH for Diabetes in Youth Study. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311:1778-1786. doi: 10.1001/jama.2014.3201.
95. Regis A. The CHILD 1 diet: from strategy to practicality. Pediatr Ann. 2013;42:178-180. doi: 10.3928/00904481-20130823-08.
96. Van Horn L, Vincent E. The CHILD 1 and DASH diets: rationale and translational applications [published correction appears in Pediatr Ann. 2013;42:427]. Pediatr Ann. 2013;42:372-374. doi: 10.3928/00904481-20130823-11.
97. LaBresh KA, Lazorick S, Ariza AJ, Furberg RD, Whetstone L, Hobbs C, de Jesus J, Bender RH, Salinas IG, Binns HJ. Implementation of the NHLBI integrated guidelines for cardiovascular health and risk reduction in children and adolescents: rationale and study design for young hearts, strong starts, a cluster-randomized trial targeting body mass index, blood pressure, and tobacco. Contemp Clin Trials. 2014;37:98-105. doi: 10.1016/j.cct.2013.11.011.
98. Faith MS, Van Horn L, Appel LJ, Burke LE, Carson JA, Franch HA, Jakicic JM, Kral TV, Odoms-Young A, Wansink B, Wylie-Rosett J; on behalf of the American Heart Association Nutrition and Obesity Committees of the Council on Nutrition; Physical Activity and Metabolism; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention, and Council on the Kidney in Cardiovascular Disease. Evaluating parents and adult caregivers as "agents of change" for treating obese children: evidence for parent behavior change strategies and research gaps: a scientific statement from the American Heart Association. Circulation. 2012;125:1186-1207. doi: 10.1161/CIR.0b013e31824607ee.
99. Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH, Sacks F, Steffen LM, Wylie-Rosett J; on behalf of the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism and the Council on Epidemiology and Prevention. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2009;120:1011-1020. doi: 10.1161/CIRCULATIONAHA.109.192627.
100. Van Horn L, Obarzanek E, Barton BA, Stevens VJ, Kwiterovich PO Jr, Lasser NL, Robson AM, Franklin FA Jr, Lauer RM, Kimm SY, Dorgan JF, Greenlick MR. A summary of results of the Dietary Intervention Study in Children (DISC): lessons learned. Prog Cardiovasc Nurs. 2003;18:28-41.
101. Fakhouri TH, Hughes JP, Burt VL, Song M, Fulton JE, Ogden CL. Physical activity in U.S. youth aged 12-15 years, 2012. NCHS Data Brief. 2014:1-8.
102. Song M, Carroll DD, Fulton JE. Meeting the 2008 Physical Activity Guidelines for Americans among U.S. youth. Am J Prev Med. 2013;44:216-222. doi: 10.1016/j.amepre.2012.11.016.
103. Physical Activity Guidelines for Americans Midcourse Report Subcommittee of the President's Council on Fitness, Sports & Nutrition. Physical Activity Guidelines for Americans Midcourse Report: Strategies to Increase Physical Activity Among Youth. Washington, DC: US Department of Health and Human Services; 2012. http://health.gov/paguidelines/midcourse/pag-mid-course-report-final.pdf. Accessed November 16, 2015.
104. Centers for Disease Control and Prevention (CDC). Current tobacco use among middle and high school students-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:581-585.
105. Centers for Disease Control and Prevention (CDC). Tobacco product use among middle and high school students-United States, 2011 and 2012 [published correction appears in MMWR Morb Mortal Wkly Rep. 2013;62:940]. MMWR Morb Mortal Wkly Rep. 2013;62:893-897.
106. Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control. 2014;23(suppl 2):ii36-ii40. doi: 10.1136/tobaccocontrol-2013-051470.
107. Grimshaw GM, Stanton A. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2006:CD003289.
108. Stanton A, Grimshaw G. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2013:CD003289.
109. Ebbert JO, Hatsukami DK, Croghan IT, Schroeder DR, Allen SS, Hays JT, Hurt RD. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. JAMA. 2014;311:155-163. doi: 10.1001/jama.2013.283185.
110. Elrashidi MY, Ebbert JO. Emerging drugs for the treatment of tobacco dependence: 2014 update. Expert Opin Emerg Drugs. 2014;19:243-260. doi: 10.1517/14728214.2014.899580.
111. Free C, Knight R, Robertson S, Whittaker R, Edwards P, Zhou W, Rodgers A, Cairns J, Kenward MG, Roberts I. Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet. 2011;378:49-55. doi: 10.1016/S0140-6736(11)60701-0.
112. Gordon JS, Mahabee-Gittens EM, Andrews JA, Christiansen SM, Byron DJ. A randomized clinical trial of a web-based tobacco cessation education program. Pediatrics. 2013;131:e455-e462. doi: 10.1542/peds.2012-0611.
113. Severson HH, Danaher BG, Ebbert JO, van Meter N, Lichtenstein E, Widdop C, Crowley R, Akers L, Seeley JR. Randomized trial of nicotine lozenges and phone counseling for smokeless tobacco cessation. Nicotine Tob Res. 2015;17:309-315. doi: 10.1093/ntr/ntu145.
114. Oberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011;377:139-146. doi: 10.1016/S0140-6736(10)61388-8.
115. Rosen LJ, Myers V, Hovell M, Zucker D, Ben Noach M. Meta-analysis of parental protection of children from tobacco smoke exposure. Pediatrics. 2014;133:698-714. doi: 10.1542/peds.2013-0958.
116. Been JV, Nurmatov UB, Cox B, Nawrot TS, van Schayck CP, Sheikh A. Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis. Lancet. 2014;383:1549-1560. doi: 10.1016/S0140-6736(14)60082-9.
117. Meyers DG, Neuberger JS, He J. Cardiovascular effect of bans on smoking in public places: a systematic review and metaanalysis [published correction appears in J Am Coll Cardiol. 1009;54:1902]. J Am Coll Cardiol. 2009;54:1249-1255. doi: 10.1016/j.jacc.2009.07.022.
118. Thomas RE, McLellan J, Perera R. School-based programmes for preventing smoking. Cochrane Database Syst Rev. 2013: CD001293.
119. Song Y, Zhao L, Palipudi KM, Asma S, Morton J, Talley B, Hsia J, Ramanandraibe N, Caixeta R, Fouad H, Khoury R, Sinha D, Rarick J, Bettcher D, Peruga A, Deland K, D'Espaignet ET; Global Adult Tobacco Survey (GATS) Collaborative Group. Tracking MPOWER in 14 countries: results from the Global Adult Tobacco Survey, 2008-2010 [published online ahead of print September 16, 2013]. Glob Health Promot. http://ped.sagepub.com/content/early/2013/09/16/1757975913501911.full.pdf. doi: 10.1177/1757975913501911. Accessed January 1, 2015.
120. Surgeon General. Preventing Tobacco Use Among Youth and Young Adults Fact Sheet. http://www.surgeongeneral.gov/library/reports/preventing-youth-tobacco-use/factsheet.html. Accessed January 1, 2015.
121. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388-2398. doi: 10.1056/NEJMsa053935.
122. Ning H, Labarthe DR, Shay CM, Daniels SR, Hou L, Van Horn L, Lloyd-Jones DM. Status of cardiovascular health in US children up to 11 years of age: the National Health and Nutrition Examination Surveys 2003-2010. Circ Cardiovasc Qual Outcomes. 2015;8:164-171. doi: 10.1161/CIRCOUTCOMES.114.001274.
123. Burke LE, Ma J, Azar KM, Bennett GG, Peterson ED, Zheng Y, Riley W, Stephens J, Shah SH, Suffoletto B, Turan TN, Spring B, Steinberger J, Quinn CC; on behalf of the American Heart Association Publications Committee of the Council on Epidemiology and Prevention, Behavior Change Committee of the Council on Cardiometabolic Health, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, Council on Quality of Care and Outcomes Research, and Stroke Council. Current science on consumer use of mobile health for cardiovascular disease prevention: a scientific statement from the American Heart Association [published correction appears in Circulation. 2015;132:e233]. Circulation. 2015;132:1157-1213. doi: 10.1161/CIR.0000000000000232.